{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:15:55Z","timestamp":1779408955967,"version":"3.53.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"JSPS KAKENHI Grant-in-Aid for Young Scientists","award":["22K16032"],"award-info":[{"award-number":["22K16032"]}]},{"name":"research grant D1 from Kansai Medical University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-44821-w","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T18:05:28Z","timestamp":1775153128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Distinct difference of pancreatic tissue-specific microbiome in autoimmune pancreatitis and pancreatic ductal adenocarcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Koh","family":"Nakamaru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsubasa","family":"Shimogama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Shijimaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomitsu","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumpei","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Orino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Ikeura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Naganuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"44821_CR1","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s00535-019-01658-7","volume":"55","author":"A Masamune","year":"2020","unstructured":"Masamune, A. et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016. J. Gastroenterol. 55, 462\u2013470 (2020).","journal-title":"J. Gastroenterol."},{"key":"44821_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103121","volume":"140","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Autoimmune pancreatitis type 2 (idiopathic duct-centric pancreatitis): A comprehensive review. J. Autoimmun. 140, 103121 (2023).","journal-title":"J. Autoimmun."},{"key":"44821_CR3","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1097\/MPA.0000000000000382","volume":"44","author":"K Okazaki","year":"2015","unstructured":"Okazaki, K. & Uchida, K. Autoimmune pancreatitis: The past, present, and future. Pancreas 44, 1006\u20131016 (2015).","journal-title":"Pancreas"},{"key":"44821_CR4","doi-asserted-by":"publisher","first-page":"9010","DOI":"10.1007\/s00330-023-09959-5","volume":"33","author":"SB Yoon","year":"2023","unstructured":"Yoon, S. B. et al. Differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma using CT characteristics: A systematic review and meta-analysis. Eur. Radiol. 33, 9010\u20139021 (2023).","journal-title":"Eur. Radiol."},{"key":"44821_CR5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/den.14076","volume":"34","author":"A Kanno","year":"2022","unstructured":"Kanno, A. et al. Endoscopic ultrasound-guided pancreatic sampling for the histopathological diagnosis of autoimmune pancreatitis. Dig. Endosc. 34, 420\u2013427 (2022).","journal-title":"Dig. Endosc."},{"key":"44821_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.canlet.2016.10.046","volume":"385","author":"G Luo","year":"2017","unstructured":"Luo, G. et al. CA19-9-low&Lewis (+) pancreatic cancer: A unique subtype. Cancer Lett. 385, 46\u201350 (2017).","journal-title":"Cancer Lett."},{"key":"44821_CR7","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.3748\/wjg.v12.i38.6225","volume":"12","author":"T Kamisawa","year":"2006","unstructured":"Kamisawa, T. et al. Pancreatic cancer with a high serum IgG4 concentration. World J. Gastroenterol. 12, 6225\u20136228 (2006).","journal-title":"World J. Gastroenterol."},{"key":"44821_CR8","doi-asserted-by":"publisher","first-page":"997","DOI":"10.21037\/hbsn-23-436","volume":"12","author":"Z Yan","year":"2023","unstructured":"Yan, Z. et al. Pancreatic carcinoma disguised as type 1 autoimmune pancreatitis with a mass-forming appearance: A clinical dilemma. Hepatobiliary Surg. Nutr. 12, 997\u20131000 (2023).","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"44821_CR9","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1111\/jgh.15163","volume":"35","author":"T Ishikawa","year":"2020","unstructured":"Ishikawa, T. et al. Risks and characteristics of pancreatic cancer and pancreatic relapse in autoimmune pancreatitis patients. J. Gastroenterol. Hepatol. 35, 2281\u20132288 (2020).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"44821_CR10","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860\u2013867 (2006).","journal-title":"Nature"},{"key":"44821_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4161\/gmic.19625","volume":"3","author":"PD Cani","year":"2012","unstructured":"Cani, P. D., Osto, M., Geurts, L. & Everard, A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 3, 279\u2013288 (2012).","journal-title":"Gut Microbes"},{"key":"44821_CR12","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.chom.2015.04.007","volume":"17","author":"KE Fujimura","year":"2015","unstructured":"Fujimura, K. E. & Lynch, S. V. Microbiota in allergy and asthma and the emerging relationship with the gut microbiome. Cell Host Microbe 17, 592\u2013602 (2015).","journal-title":"Cell Host Microbe"},{"key":"44821_CR13","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","volume":"146","author":"AD Kostic","year":"2014","unstructured":"Kostic, A. D., Xavier, R. J. & Gevers, D. The microbiome in inflammatory bowel disease: Current status and the future ahead. Gastroenterology 146, 1489\u20131499 (2014).","journal-title":"Gastroenterology"},{"key":"44821_CR14","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/s41401-020-00532-0","volume":"42","author":"LL Pan","year":"2021","unstructured":"Pan, L. L., Li, B. B., Pan, X. H. & Sun, J. Gut microbiota in pancreatic diseases: Possible new therapeutic strategies. Acta Pharmacol. Sin. 42, 1027\u20131039 (2021).","journal-title":"Acta Pharmacol. Sin."},{"key":"44821_CR15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/intimm\/dxac036","volume":"34","author":"D Daley","year":"2022","unstructured":"Daley, D. The role of the microbiome in pancreatic oncogenesis. Int. Immunol. 34, 447\u2013454 (2022).","journal-title":"Int. Immunol."},{"key":"44821_CR16","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/ueg2.70025","volume":"13","author":"V Dovhalyuk","year":"2025","unstructured":"Dovhalyuk, V. et al. Differences in the fecal metabolome of autoimmune pancreatitis patients. United Eur. Gastroenterol. J. 13, 1560\u20131570 (2025).","journal-title":"United Eur. Gastroenterol. J."},{"key":"44821_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1620\/tjem.244.113","volume":"244","author":"S Hamada","year":"2018","unstructured":"Hamada, S., Masamune, A., Nabeshima, T. & Shimosegawa, T. Differences in gut microbiota profiles between autoimmune pancreatitis and chronic pancreatitis. Tohoku J. Exp. Med. 244, 113\u2013117 (2018).","journal-title":"Tohoku J. Exp. Med."},{"key":"44821_CR18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1053\/j.gastro.2022.03.054","volume":"163","author":"N Nagata","year":"2022","unstructured":"Nagata, N. et al. Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study. Gastroenterology 163, 222\u2013238 (2022).","journal-title":"Gastroenterology"},{"key":"44821_CR19","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/intimm\/dxac039","volume":"34","author":"T Yoshikawa","year":"2022","unstructured":"Yoshikawa, T. et al. Disruption of the intestinal barrier exacerbates experimental autoimmune pancreatitis by promoting the translocation of Staphylococcus sciuri into the pancreas. Int. Immunol. 34, 621\u2013634 (2022).","journal-title":"Int. Immunol."},{"key":"44821_CR20","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.18632\/oncotarget.3109","volume":"6","author":"K Mitsuhashi","year":"2015","unstructured":"Mitsuhashi, K. et al. Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget 6, 7209\u20137220 (2015).","journal-title":"Oncotarget"},{"key":"44821_CR21","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/MPA.0b013e3182142fd2","volume":"40","author":"T Shimosegawa","year":"2011","unstructured":"Shimosegawa, T. et al. International consensus diagnostic criteria for autoimmune pancreatitis: Guidelines of the International Association of Pancreatology. Pancreas 40, 352\u2013358 (2011).","journal-title":"Pancreas"},{"key":"44821_CR22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/gutjnl-2017-314205","volume":"67","author":"RM Ferreira","year":"2018","unstructured":"Ferreira, R. M. et al. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut 67, 226\u2013236 (2018).","journal-title":"Gut"},{"key":"44821_CR23","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","volume":"15","author":"D Gevers","year":"2014","unstructured":"Gevers, D. et al. The treatment-naive microbiome in new-onset Crohn\u2019s disease. Cell Host Microbe 15, 382\u2013392 (2014).","journal-title":"Cell Host Microbe"},{"key":"44821_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-04095-w","volume":"12","author":"CS Chu","year":"2022","unstructured":"Chu, C. S. et al. Endoscopic ultrasound-guided fine-needle biopsy as a tool for studying the intra-tumoral microbiome in pancreatic ductal adenocarcinoma: A pilot study. Sci. Rep. 12, 107 (2022).","journal-title":"Sci. Rep."},{"key":"44821_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5009\/gnl240380","volume":"19","author":"K Minaga","year":"2025","unstructured":"Minaga, K. et al. Gut microbiota involved in the immunopathogenesis of autoimmune pancreatitis. Gut Liver 19, 171\u2013176 (2025).","journal-title":"Gut Liver"},{"key":"44821_CR26","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/clinids\/22.2.384","volume":"22","author":"I Brook","year":"1996","unstructured":"Brook, I. & Frazier, E. H. Microbiological analysis of pancreatic abscess. Clin. Infect. Dis. 22, 384\u2013385 (1996).","journal-title":"Clin. Infect. Dis."},{"key":"44821_CR27","doi-asserted-by":"publisher","first-page":"e0182025","DOI":"10.1128\/spectrum.01820-25","volume":"13","author":"ZA Khan","year":"2025","unstructured":"Khan, Z. A. et al. Survival mechanism of pancreatic tumor bacteria and their ability to metabolize chemotherapy drugs. Microbiol. Spectr. 13, e0182025 (2025).","journal-title":"Microbiol. Spectr."},{"key":"44821_CR28","doi-asserted-by":"publisher","first-page":"1553034","DOI":"10.3389\/fimmu.2025.1553034","volume":"16","author":"P Tajpara","year":"2025","unstructured":"Tajpara, P. et al. Patient-derived pancreatic tumor bacteria exhibit oncogenic properties and are recognized by MAIT cells in tumor spheroids. Front Immunol. 16, 1553034 (2025).","journal-title":"Front Immunol."},{"key":"44821_CR29","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1002\/ijc.34460","volume":"152","author":"H Zhu","year":"2023","unstructured":"Zhu, H. et al. Convergent dysbiosis of upper aerodigestive microbiota between patients with esophageal and oral cavity squamous cell carcinoma. Int. J. Cancer 152, 1903\u20131915 (2023).","journal-title":"Int. J. Cancer"},{"key":"44821_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00087","volume":"7","author":"MA Kowalik","year":"2017","unstructured":"Kowalik, M. A., Columbano, A. & Perra, A. Emerging role of the Pentose Phosphate Pathway in hepatocellular carcinoma. Front. Oncol. 7, 87 (2017).","journal-title":"Front. Oncol."},{"key":"44821_CR31","first-page":"4213","volume":"17","author":"L Jin","year":"2019","unstructured":"Jin, L. & Zhou, Y. Crucial role of the pentose phosphate pathway in malignant tumors. Oncol. Lett. 17, 4213\u20134221 (2019).","journal-title":"Oncol. Lett."},{"key":"44821_CR32","doi-asserted-by":"publisher","first-page":"663068","DOI":"10.3389\/fcimb.2021.663068","volume":"11","author":"JW Chen","year":"2021","unstructured":"Chen, J. W. et al. Taxonomic and functional dysregulation in salivary microbiomes during oral carcinogenesis. Front. Cell. Infect. Microbiol. 11, 663068 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"44821_CR33","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1186\/s12967-025-06797-5","volume":"23","author":"H Soleimani Samarkhazan","year":"2025","unstructured":"Soleimani Samarkhazan, H., Nouri, S., Maleknia, M. & Aghaei, M. The microbiome in graft-versus-host disease: A tale of two ecosystems. J. Transl. Med. 23, 832 (2025).","journal-title":"J. Transl. Med."},{"key":"44821_CR34","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/cei.13509","volume":"202","author":"K Kamata","year":"2020","unstructured":"Kamata, K. et al. Gut microbiomealterations in type 1 autoimmune pancreatitis after induction of remission by prednisolone. Clin. Exp. Immunol. 202, 308\u2013320 (2020).","journal-title":"Clin. Exp. Immunol."},{"key":"44821_CR35","doi-asserted-by":"publisher","first-page":"100779","DOI":"10.1016\/j.gastha.2025.100779","volume":"5","author":"A Takaori","year":"2025","unstructured":"Takaori, A. et al. Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Cancer. Gastro Hep Adv. 5, 100779 (2025).","journal-title":"Gastro Hep Adv."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44821-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44821-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44821-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T23:26:09Z","timestamp":1779405969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44821-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["44821"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-44821-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All the participants provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}},{"value":"This study was approved by the Medical Ethics Committee of the Fujita Health University (ID: HM18-094).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}}],"article-number":"15944"}}